Manlikeclix our Fashion forward man of Cameroon origin is the official Creative Director for Alessandro Veneto ! A Unique Fashion Brand in Florence – Italy. News reaching our desk from a closed friend of him has it that, the young Cameroonian Entrepreneur and Fashion designer closed a deal last November 2019 with this company worth a whooping some of $1M (approximately 600,000,000frs ), The sum of money involved will aswell be tax deducted 20%, legal fees and other charges which still sums of up to make him take home an amount of approximately $600,000 ( 400,000,000 frs ) Oh lord !. His job already started as images of his first job as a Creative Director has been circulating on his facebook and on his instagram @manlikeclx. His job will be to style, create content and identify various mood boards for the image of the unique fashion brand. Now wondering what led to such a succesful deal? Manlikeclix who’s name is Gwei Noel Yengong has proved to be very serious in the domain of fashion, sharing and teaching Men tricks and secrets to bringing your image forward and be represented over some few years now. He appeared on elle.com magazine , esquire.com at Pitti Uomo Men’s fashion in Italy where he caught the attention of several fashion companies that landed him now to what we are all seeing. He has a good eye for what will look extremely good on camera in terms of fashion and considered the champion of Cameroon Fashion Consulting in all weather. Manlikeclix is very influencial and has been seen alot with celebrities of all categories ranging from Jovi, 2baba , Beenie Man Jamai Wizkid and many more. For the best of Fashion and lifestyle visit IG @manlikeclix
,
Manlikeclix Signs $1M Creative Director Deal with Italian Fashion Company

In our in vitro study, we needed to keep the rate of adaptation low for the above theoretical rationale to work, and only certain sequential treatments were able to do this Fig buy nolvadex
tadalafil cialis from india In cases of maintaining urine concentrating abilities, tolvaptan may be the treatment of choice for CKD patients with fluid retention